AN2 Therapeutics Inc is a global name in the pharmaceutical sector. The company focuses on the discovery, development and commercialisation of new therapies for patients with severe lung diseases. It operates on a global scale, using a strategic approach to innovation and research.
Part of the pharmaceutical industry, AN2 Therapeutics Inc works to treat rare, chronic and serious infectious diseases. It provides novel therapies, focusing on patient care and advancing medicinal knowledge. The company also has a strategic partnership with Brii Biosciences. 
Monitor the ANTX share price by adding it to your eToro watchlist.